Kodiak Sciences Inc. (KOD)
NASDAQ: KOD
· Real-Time Price · USD
4.04
-0.09 (-2.18%)
At close: May 13, 2025, 3:59 PM
4.18
3.47%
After-hours: May 13, 2025, 07:12 PM EDT
-2.18% (1D)
| Bid | 3.68 |
| Market Cap | 213.16M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -176.21M |
| EPS (ttm) | -3.35 |
| PE Ratio (ttm) | -1.21 |
| Forward PE | -1.08 |
| Analyst | Hold |
| Ask | 4.5 |
| Volume | 285,663 |
| Avg. Volume (20D) | 399,625 |
| Open | 4.17 |
| Previous Close | 4.13 |
| Day's Range | 3.91 - 4.09 |
| 52-Week Range | 1.92 - 11.60 |
| Beta | 2.43 |
Analyst Forecast
According to 0 analyst ratings, the average rating for KOD stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts5 months ago
+29.63%
Kodiak Sciences shares are trading higher after Je...
Unlock content with
Pro Subscription
2 months ago · seekingalpha.com
Kodiak Sciences: Anti-VEGF Could Win Nicely On Retinal DisordersKodiak Sciences basically uses a novel biopolymer conjugate platform to develop more durable, next-generation retinal disease therapies. Today, KOD's pipeline includes Phase 3 candidates for DR, RVO, ...